Merrion Pharmaceuticals

Pharmaceutical Manufacturing • Dublin 24, Co Dublin, Ireland • 1-10 Employees

Company overview

Headquarters	3200 Lake Drive, Citywest Business Campus, Dublin, Dublin Dublin 24, IE
Phone number	+35319107991847
Website	merrionpharma.com
NAICS	3254
SIC	591
Employees	1-10
Socials

Key Contact at Merrion Pharmaceuticals

Kailas Mahadevaiah

Director of Business Development

About Merrion Pharmaceuticals

Merrion Pharmaceuticals is a publicly listed product development company focused on delivering innovation to the market by: designing our own patented products and partnering with other pharmaceutical companies to develop patented products. Established in 2003, Merrion are engaged in the development of oral forms (tablets/capsules) of drugs that have poor absorption and are generally given by injection. Merrion Pharmaceutical's patented drug delivery technology (GIPET®) hugely increase bioavailability, by improving absorption in the gastrointestinal tract, of drugs that are otherwise poorly absorbed. As well as increasing absorption, Merrion's Technology also increases the consistency of absorption. These new products can provide substantial benefits in enhanced drug efficacy, improved safety, toxicity and side effect profile, health economics, patient experience and quality of life. Merrion is listed on the Irish Stock Exchange (ESM) under the symbol MERR.

Merrion Pharmaceuticals revenue & valuation

Annual revenue	$20,100,000
Revenue per employee	$20,092,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$64,300,000
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Merrion Pharmaceuticals has never raised funding before.